These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 8614850)

  • 21. New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer.
    Awada A
    Forum (Genova); 2002; 12(1):4-15. PubMed ID: 12634907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
    Wu Y; Zhong Z; Huber J; Bassi R; Finnerty B; Corcoran E; Li H; Navarro E; Balderes P; Jimenez X; Koo H; Mangalampalli VR; Ludwig DL; Tonra JR; Hicklin DJ
    Clin Cancer Res; 2006 Nov; 12(21):6573-84. PubMed ID: 17085673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic role of angiogenesis in breast cancer.
    Leek RD
    Anticancer Res; 2001; 21(6B):4325-31. PubMed ID: 11908687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
    Tan M; Li P; Sun M; Yin G; Yu D
    Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer.
    Hiscox S; Morgan L; Green T; Nicholson RI
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S53-9. PubMed ID: 17259559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Breast cancer and polypeptide growth factors].
    Rømer J; Holst-Hansen C; Moser C; Brünner N
    Nord Med; 1992; 107(2):49-52. PubMed ID: 1538961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Local growth factors for breast cancer: general review and potential value for clinician].
    Piccart MJ; Devleeschouwer N; Leclercq G; L'Hermite M
    Bull Cancer; 1991; 78(3):215-27. PubMed ID: 1647237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic consequences of molecular biology advances in oncology].
    Bauvet F; Awada A; Gil T; Hendlisz A
    Bull Cancer; 2009 Jan; 96(1):59-71. PubMed ID: 19211361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biological prognostic factors of cancers of the breast and their consequences on the therapeutic choice].
    Remvikos Y; Dutrillaux B
    Arch Anat Cytol Pathol; 1994; 42(5):262-8. PubMed ID: 7872817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of the biologic markers of breast cancer.
    Porter-Jordan K; Lippman ME
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):73-100. PubMed ID: 8150784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in the management of lung and breast cancer. Future directions.
    Salmon SE
    Semin Oncol; 1990 Aug; 17(4 Suppl 7):50-2. PubMed ID: 2382147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenes, tumour suppressor genes and growth factors in breast cancer: novel targets for diagnosis, prognosis and therapy.
    Callahan R; Salomon DS
    Cancer Surv; 1993; 18():35-56. PubMed ID: 8012999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth factors, cytokines and soluble forms of receptor molecules in cancer patients.
    Zumkeller W; Schofield PN
    Anticancer Res; 1995; 15(2):343-8. PubMed ID: 7763004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy: updates and new perspectives.
    Swain SM
    Oncologist; 2011; 16 Suppl 1():30-9. PubMed ID: 21278439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenesis and breast cancer.
    Hayes DF
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):51-71. PubMed ID: 7512088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward checkmate: biology and breast cancer therapy for the new millennium.
    Miller KD; Sledge GW
    Invest New Drugs; 1999; 17(4):417-27. PubMed ID: 10759407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting AAC-11 in cancer therapy.
    Faye A; Poyet JL
    Expert Opin Ther Targets; 2010 Jan; 14(1):57-65. PubMed ID: 20001210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Embryo implantation and tumor metastasis: common pathways of invasion and angiogenesis.
    Murray MJ; Lessey BA
    Semin Reprod Endocrinol; 1999; 17(3):275-90. PubMed ID: 10797946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.